Tiantian Zhang | Health Professions | Best Researcher Award

Posted on 02/12/202402/12/2024 by ScienceFather

Dr. Tiantian Zhang | Health Professions | Best Researcher Award

Dr. Tiantian Zhang, Fudan University, China

Dr. Tiantian Zhang is a dedicated researcher in the field of public health, specializing in the construction of public health systems and proactive health technologies within the context of medical health big data. Currently serving as a Youth Researcher at the School of Public Health at Fudan University since October 2023, she brings an academic background with a Master’s and Doctorate in Management, focusing on social medicine and health management from Fudan University. She has contributed significantly to over 38 publications, with many in high-impact journals, particularly in health policy, public health emergency responses, and chronic disease prevention. Her research also covers the intersection of technology, public health, and healthcare systems. She has been involved in various research projects and has received substantial funding for her work. Dr. Zhang’s academic journey includes postdoctoral research and entrepreneurial experience in management science and data science. Additionally, she is a key member of national projects on public health and disease prevention.

Publication Profile

Scopus

Academic Background 🎓📚

Dr. Tiantian Zhang pursued her graduate studies at Fudan University, where she earned a Master’s degree in Management with a focus on Social Medicine and Health Administration from September 2016 to June 2018. 🏫🎓 She continued her academic journey at Fudan, completing a PhD in Management in the same field from June 2018 to June 2021. 🔬 Her doctoral research contributed to advancing public health management and policy, further establishing her expertise in healthcare systems and social medicine. Dr. Zhang’s academic foundation laid the groundwork for her current work in public health and health data research. 🌟📊

Professional and Visiting Scholar Experience 💼🌍

Dr. Tiantian Zhang has held various esteemed positions in her career. Since October 2023, she has been serving as a Youth Researcher at Fudan University, focusing on Health Management. 🏫🧑‍🔬 From June 2021 to September 2023, she worked as a Postdoctoral Researcher at Fudan University, specializing in Public Policy. 📜🔍 Additionally, since September 2017, Dr. Zhang has been the founder and legal representative of Shanghai Haiyu Information Technology Co., Ltd., where she applies her expertise in Management Science and Data Science. 💻📊 Her diverse roles reflect her commitment to advancing healthcare and policy through innovation. 🌟

Research Achievements and Contributions 📚🏆

Dr. Tiantian Zhang, a Youth Researcher at Fudan University’s School of Public Health, has made significant contributions to healthcare management research. She has co-authored 9 policy briefs, receiving positive feedback from top political leaders, including members of the Central Political Bureau. 👩‍🔬✨ She has led a National Natural Science Foundation Youth Project and 7 provincial projects, while also contributing to major national R&D initiatives. Her research includes 37 published papers, 8 of which are in high-impact journals (SCI/SSCI, JCR-Q1), with a total impact factor of 68.5. 📝📊 Dr. Zhang has received multiple prestigious awards, including the Shanghai Decision-Making Advisory Research Awards and the Shanghai Youth Medal. 🏅

Academic Positions and Editorial Roles 📚🌟

Dr. Tiantian Zhang holds several prestigious academic roles. She is a Youth Elite Talent for the Shanghai Municipal Government Decision-Making Consulting Research Base (2024–2026) and an expert in Shanghai’s healthcare reform (2022–2025). 🏅 She serves on the Youth Committee of the Shanghai Medical Association’s Health Management Branch and is a director of the Chinese Medicine Informatics Society. 🩺 Additionally, she contributes to several academic journals, including Chinese Hospital Management and Chinese Public Health Management, where she holds youth editorial board positions. ✍️ She is also involved in writing and editing key publications, including the fifth edition of Health Management and the Blue Book on Proactive Health and Healthy Aging. 📖

Research Focus

Dr. Tiantian Zhang’s research focuses on public health management, health policy, and health data science. She is particularly interested in the intersection of healthcare system development and technology for proactive health and aging. 🏥 Her work includes studies on health equity, air pollution, dyslipidemia, and disease prevention, and she frequently contributes to research on health disparities and socioeconomic factors affecting public health. 🌍 Additionally, she explores health management practices and decision-making frameworks for improving healthcare services, with a strong emphasis on government regulation and community-based health interventions. 📊

Publication Top Notes

Association of circadian syndrome with risk of hyperuricemia among middle-aged and older adults in China – 2025 🕰️,
Research on government regulation methods for the spatial layout of retail pharmacies – 2024 🏪
Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai – 2024 ⚖️,
Global Justice Index Report 2023 – 2024 🌍, Cited by: 2 📑.
Association of long-term exposure to air pollutants with sensory impairment in middle-aged and elderly adults – 2024 🌫️
Equity analysis of older adult resource allocation in China – 2024 💼
Development of an assessment tool for designated medical institutions in China – 2024 💻
Association of indoor solid fuel use and long-term exposure to ambient PM2.5 with sarcopenia in China – 2023 🌫️, Cited by: 10 📑.
Global Justice Index Report 2022 – 2023 🌍, Cited by: 7 📑.

Min-ran Li | Medicine and Dentistry | Women Researcher Award

Posted on 17/10/202417/10/2024 by ScienceFather

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. 🏥📚

Publication Profile

Scopus

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

Publication Top Notes

Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. 🥗 (0 citations)
Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. 🍔 (1 citation)
Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. 💉 (1 citation)
Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. 🏥 (0 citations)
Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. 🔬 (20 citations)
Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Posted on 12/10/202412/10/2024 by ScienceFather

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Prof Ashwani Singal, University of Louisville School of Medicine, United States

Prof. Ashwani Singal, he appears to be a highly suitable candidate for the Best Researcher Award. Here are several reasons supporting this nomination:

Publication Profile

Google Scholar

Research and Academic Excellence

Extensive Education: Prof. Singal holds an MBBS, MD in Medicine, and a DM in Gastroenterology, along with postdoctoral training in Transplant Hepatology and Gastroenterology from prestigious institutions like Mayo Clinic and UTMB Galveston.
Publications: He has a substantial publication record, including influential papers on liver diseases, alcoholic liver disease, and hepatitis C, demonstrating his contributions to advancing medical knowledge in his field. His work has been recognized in reputable journals and conferences, with multiple posters of distinction presented at AASLD annual conferences.

Clinical Impact

Leadership Roles: As the Medical Director of Liver Transplant at the Trager Transplant Institute and a Transplant Hepatologist at Avera Transplant Institute, he plays a critical role in clinical practice and patient care, impacting many lives.
Current Support: His involvement in multiple funded research projects indicates ongoing commitment to advancing research in alcohol use disorders and liver diseases, with significant financial backing from NIH and other organizations.

Contributions to Medical Education

Teaching and Mentoring: Prof. Singal has extensive experience in teaching medical students and residents across various institutions, having served as a course director and providing numerous lectures and grand rounds. His mentorship has led to several mentees receiving awards for their research.

Professional Engagement

Committee Involvement: He has served on numerous committees and councils within professional societies, showcasing his dedication to improving the field of gastroenterology and hepatology.
Editorial Roles: Prof. Singal is active in the editorial boards of reputable journals, contributing to the peer-review process and shaping future research directions in his specialty.

Recognition and Awards

Recent Nominations: His nomination for the Clinical Innovation Award by the Healio-American College of Gastroenterology and his status as an International Fellow of the National Academy of Medical Science in India highlight his recognition as a leader in his field.

Publication Top Notes

ACG clinical guideline: alcoholic liver disease

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Antioxidants as therapeutic agents for liver disease

Hepatitis C virus and hepatocellular carcinoma: a narrative review

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosis

Mesenteric venous thrombosis

Conclusion

Prof. Ashwani Singal’s extensive academic credentials, significant clinical contributions, commitment to education, active engagement in professional societies, and recognition in the form of awards and nominations make him an exemplary candidate for the Best Researcher Award. His work not only contributes to advancing medical knowledge but also directly impacts patient care and the training of future healthcare professionals.

khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Posted on 06/09/202406/09/2024 by ScienceFather

Dr. khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Dr. khadijeh kalanfarmanfarma, Kashan University of Medical Sciences, Kashan, Iran

Dr. Khadijeh Kalan Farmanfarma (born April 24, 1978) holds a PhD in Epidemiology and an M.Sc. in Health Education and Promotion. She has been recognized as a top researcher at both the national and university levels, notably at Zahedan University of Medical Sciences. Dr. Farmanfarma has contributed to over 20 high-impact publications, focusing on cancer epidemiology, metabolic syndrome, and public health. She is also a co-author of an eBook on the Renin-Angiotensin System and its role in diseases. Her research has earned her awards and recognition both nationally and internationally. 📚🌍🔬

Publication profile

Scopus

Google Scholar

Academic Background 🧠

Dr. Khadijeh Kalan Farmanfarma holds a PhD in Epidemiology and an M.Sc. in Health Education and Health Promotion. Her solid academic foundation is supported by multiple recognitions at the doctoral and master’s levels. Her focus on epidemiological research is crucial, particularly during global health challenges like COVID-19.

Research Contributions 📚

Dr. Farmanfarma has an impressive body of work, with more than 25 published research articles across Q1 to Q3 journals. Some highlights include:

COVID-19 Research: Her studies on the impact of COVID-19, especially on domestic violence and illness anxiety, show her commitment to addressing emerging public health issues.

Metabolic Syndrome & Cancer Epidemiology: Dr. Farmanfarma has published meta-analyses on metabolic syndrome and various cancers, which have gained significant attention in high-impact journals like Diabetes & Metabolic Syndrome: Clinical Research & Reviews (IF: 10.0, Q1).

Chronic Diseases & Breast Cancer Prevention: Her focus on chronic diseases and breast cancer prevention demonstrates her dedication to improving population health.

Recognitions 🏆

Dr. Farmanfarma’s accolades include being named the Top National Researcher and Top Researcher at Zahedan University of Medical Sciences multiple times, which speaks to her consistent excellence in research.

Publication Top Notes

📚 Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies – Cited by: 248 (2018)
📚 Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies – Cited by: 149 (2019)
🧠 Brain cancer in the world: An epidemiological review – Cited by: 79 (2019)
🎗️ Improving Breast Cancer Preventive Behavior among Female Medical Staff: Educational Intervention – Cited by: 59 (2014)
📊 Epidemiologic study of gastric cancer in Iran: A systematic review – Cited by: 51 (2020)
📈 Prevalence of type 2 diabetes in Middle-East: Systematic review & meta-analysis – Cited by: 47 (2020)
🎗️ Effect of education on preventive behaviors of breast cancer in female teachers – Cited by: 35 (2014)
🩺 Study of breast cancer knowledge, attitude, and preventive behaviors in Yazd, Iran – Cited by: 22 (2017)
📊 Prevalence and trend of metabolic syndrome in South-East Iran – Cited by: 21 (2020)
🧬 Testicular cancer in the world: An epidemiological review – Cited by: 20 (2018)

Conclusion 📝

With her extensive research output, recognitions, and focus on significant public health issues, Dr. Khadijeh Kalan Farmanfarma is a strong candidate for the Research for Best Researcher Award. Her diverse and impactful research contributions in epidemiology, particularly in chronic diseases and cancer, reflect a distinguished career deserving of recognition.

Chiara Villa | Health Professions | Best Researcher Award

Posted on 29/08/202429/08/2024 by ScienceFather

Chiara Villa | Health Professions | Best Researcher Award

Dr Chiara Villa, INSTITUT COCHIN U1016 Inserm/CNRS/UMR-S8104 -Université de Paris, France

Dr. Chiara Villa appears to be a highly suitable candidate for the Best Researcher Award based on her extensive academic background, professional achievements, and research contributions. Here’s an evaluation based on key aspects of her career:

Publication profile

Orcid

Academic Qualifications 📚

Dr. Villa has an impressive academic foundation, starting with a Baccalauréat in science and Latin, and advancing to earn a Doctor of Medicine degree from the University of Pavia, Italy. Her specialization in Anatomical Pathology and a Ph.D. in Sciences underscore her deep commitment to advancing her knowledge and expertise. Her Ph.D. work focused on predictive factors in silent pituitary adenomas, a crucial area in pathology and endocrinology, demonstrating her specialized research capabilities.

Professional Experience 🏥

Her professional trajectory includes significant roles in various prestigious institutions, such as the Centre Hospitalier Sainte Anne and Hôpital Foch, Paris. Her positions have ranged from Praticien Attaché to Médecin Spécialiste in Cytology and Anatomical Pathology. These roles highlight her extensive experience in neuropathology and cytopathology, positioning her as a leader in her field.

Research Contributions and Publications 📑

Dr. Villa’s research contributions are notable, with numerous publications in high-impact journals covering various topics, including molecular prognostic factors in gastric carcinoma and immunological pathways in lung diseases. Her work on pituitary adenomas, including diagnostic and prognostic markers, has provided valuable insights into the management of these conditions. The range and depth of her publications reflect her influence in advancing medical knowledge and patient care.

Conference Presentations 🎤

Dr. Villa has been an invited speaker at several key international conferences, presenting on topics like histological prognostic factors in pituitary tumors and the role of AIP mutations in pituitary tumorigenesis. These invitations underscore her recognition as an expert in her field and her ability to contribute to scientific discourse on a global scale.

Conclusion 🌟

Dr. Chiara Villa’s combination of advanced academic credentials, extensive professional experience, and significant research contributions make her a highly deserving candidate for the Best Researcher Award. Her work has not only advanced understanding in the fields of pathology and endocrinology but also has practical implications for patient diagnosis and treatment.

Publication top notes

Germline loss-of-function<i>PAM</i>variants are enriched in subjects with pituitary hypersecretion

Corticotroph tumor progression speed after adrenalectomy

Molecular genetics and new classification of pituitary adenomas,Génétique moléculaire et nouvelle classification des adénomes hypophysaires

Outcome of giant pituitary tumors requiring surgery

Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study

Zahra Maleki | Health Professions | Best Researcher Award

Posted on 27/08/202427/08/2024 by ScienceFather

Zahra Maleki | Health Professions | Best Researcher Award

Ms Zahra Maleki, Tabriz university of medical sciences, Iran

Based on Ms. Zahra Maleki’s academic and professional background, she appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

google scholar

Academic Excellence

Ms. Maleki has consistently demonstrated academic excellence, ranking first in her Master’s program and third in her Bachelor’s program in Occupational Therapy. Her high grades and ranking throughout her educational journey reflect her dedication and knowledge in her field.

Research Experience

She has actively engaged in research, authoring several papers focusing on child development, critical thinking skills in occupational therapy students, and qualitative studies on pediatric care. Her research publications in reputable journals and ongoing involvement in various studies highlight her contributions to advancing knowledge in occupational therapy and child development.

Teaching and Academic Contributions

With experience as a faculty member at Tabriz University of Medical Sciences, she has taught numerous courses and supervised students, contributing significantly to the academic and professional development of future therapists.

Workshops and Congress Participation

Ms. Maleki has been involved in delivering workshops and presentations at national and international conferences. Her active role in sharing knowledge and best practices through speaking engagements underscores her commitment to the field.

Awards and Recognition

She has received awards for educational excellence, including recognition for her short-term developmental care program for infants and children.

Multidisciplinary Approach

Her involvement in multidisciplinary approaches to pediatric care and her focus on developmental issues in children demonstrate her holistic approach and adaptability in various research and educational settings.

Overall, Ms. Zahra Maleki’s strong academic background, extensive research experience, teaching roles, active participation in conferences, and recognized contributions to occupational therapy and child development make her a worthy candidate for the Best Researcher Award.

Publication top notes

Effect of meteorological factors and Air Quality Index on the COVID-19 epidemiological characteristics: an ecological study among 210 countries

Survival rate of colorectal cancer in eastern mediterranean region countries: A systematic review and meta-analysis

Ecological study of ambient air pollution exposure and mortality of cardiovascular diseases in elderly

The Impact of Quarantine, Isolation, and Social Distancing on COVID-19 Prevention: A Systematic Review

Epidemiological Patterns of Animal Bites in the Najafabad, Center of Iran (2012–2017)

Relationships Between Job Satisfaction of Operating Room Nurses and Hospital’s Compliance With Protective Guidelines During the Covid-19 Pandemic: A Cross-Sectional Study, Iran

Characteristics of hospitalized patients due to intentional and unintentional poisoning in Fasa city, 2014-2016

Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis

Incidence and maternal-fetal risk factors of stillbirth. A population-based historical cohort and a nested casecontrol study

James Yue | Health Professions Award | Best Researcher Award

Posted on 16/08/202416/08/2024 by ScienceFather

Dr. James Yue | Health Professions Award | Best Researcher Award

Dr. James Yue, Frank H Netter School of Medicine/ CT Orthopaedics, United States

Dr. James J. Yue’s impressive career makes him a strong candidate for the Research for Best Researcher Award.

Publication profile

Scopus

Extensive Expertise

Dr. Yue is a renowned spinal surgeon with a significant academic and clinical background, including leadership roles and contributions to major institutions like Quinnipiac University and Yale University.

Innovative Contributions

He has pioneered numerous advancements in spinal surgery, notably through founding specialized centers such as the Northeast Alliance Surgery Center and the New England Center for Disc Replacement.

Recognized Achievements

His awards, including multiple “Best Doctor” titles and the Gunnar B. Andersson Distinguished Service Award, highlight his contributions and recognition in his field.

Research Impact

Dr. Yue’s extensive bibliography, with numerous peer-reviewed articles, showcases his research impact and ongoing commitment to advancing spinal surgery techniques and treatments.

Publication Top Notes

“Surgical treatment of refractory low back pain using implanted BurstDR spinal cord stimulation (SCS) in a cohort of patients without options for corrective surgery: Findings and results from the DISTINCT study, a prospective randomized multi-center-controlled trial” – Yue, J.J., Gilligan, C.J., Falowski, S., Okaro, U., Deer, T. (2024) North American Spine Society Journal – 🩺
“Endovascular stenting of external iliac vein injury during anterior spine exposure” – Arun, A.S., Yue, J.J., Khachane, V.B., Sumpio, B., Tonnessen, B.H. (2024) Journal of Vascular Surgery Cases, Innovations and Techniques – 🩺
“Paired Comparison Survey Analysis Utilizing Rasch Methodology of the Relative Difficulty and Estimated Work Relative Value Units of CPT Code 0202T” – Lorio, M., Lewandrowski, K.-U., Yeager, M.T., Kube, R., Yue, J. (2024) International Journal of Spine Surgery – 📊
“A novel antibacterial compound decreases MRSA biofilm formation without the use of antibiotics in a murine model” – Bouloussa, H., Durand, Z., Gibon, E., Bouloussa, O., Croisier, D. (2024) Journal of Orthopaedic Research – 🦠
“Implant Surface Technologies to Prevent Surgical Site Infections in Spine Surgery” – Bouloussa, H., Mirza, M., Ansley, B., Jilakara, B., Yue, J.J. (2023) International Journal of Spine Surgery – 🦠
“Treatment of Refractory Low Back Pain Using Passive Recharge Burst in Patients Without Options for Corrective Surgery: Findings and Results From the DISTINCT Study, a Prospective Randomized Multicenter Controlled Trial” – Deer, T., Gilligan, C., Falowski, S., Fahey, M.E., Yue, J. (2023) Neuromodulation – 🩺
“Burst spinal cord stimulation can attenuate pain and its affective components in chronic pain patients with high psychological distress: results from the prospective, international TRIUMPH study” – Hagedorn, J.M., Falowski, S.M., Blomme, B., Capobianco, R.A., Yue, J.J. (2022) Spine Journal – 💥
“Final long-term reporting from a randomized controlled IDE trial for lumbar artificial discs in single-level degenerative disc disease: 7-year results” – Radcliff, K., Zigler, J., Braxton, E., Situ, A., Yue, J. (2021) International Journal of Spine Surgery – ⏳
“Postoperative Bracing on Pain, Disability, Complications, and Fusion Rate following 1-3+ Level Lumbar Fusion in Degenerative Conditions: A Meta-Analysis” – Jones, J.J., Oduwole, S., Feinn, R., Yue, J.J. (2021) Clinical Spine Surgery – 📉
“International society for the advancement of spine surgery policy 2019-surgical treatment of lumbar disc herniation with radiculopathy” – LORIO, M., KIM, C., ARAGHI, A., INZANA, J., YUE, J.J. (2020) International Journal of Spine Surgery – 📜

Conclusion

Given these factors, Dr. Yue’s profile aligns well with the criteria for the Research for Best Researcher Award, making him a suitable candidate.

Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Posted on 09/08/202409/08/2024 by ScienceFather

Dr. Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Dr. Rainer Pooth, ICAAN GmbH, Germany

Based on the information provided, Dr. Rainer Pooth appears to be a highly suitable candidate for the “Research for Best Innovation Award” in the pharmaceutical and medical industry. Here’s an assessment of his qualifications:

Publication profile

Scopus

Orcid

Professional Experience & Leadership

Dr. Pooth has over 20 years of experience in the global pharmaceutical and medical industry, with a strong track record of leadership in multidisciplinary teams at both global and affiliate levels. His roles as Managing Director, Global Head of Medical/Scientific Affairs, and Head of Global Clinical Development demonstrate his ability to lead and innovate in complex, highly regulated environments. His strategic input in global R&D programs, project management, and regulatory affairs underscores his expertise in driving innovation and ensuring successful product development.

Achievements & Expertise

Dr. Pooth’s achievements include multiple approvals of medicinal products and medical devices across key global markets such as the EU, US, Australia, and Asia. He holds more than 35 patents, with a significant portion becoming commercially relevant, highlighting his innovative contributions to the field. His extensive publication record, including over 50 publications in international journals and books, as well as his role as an invited speaker at major scientific congresses, further cements his reputation as a leader in pharmaceutical research and innovation.

Global Impact & Collaboration

Dr. Pooth’s global network of experts and key opinion leaders, along with his experience in managing international submission teams and regulatory interactions, illustrates his ability to navigate and influence the global pharmaceutical landscape. His leadership in directing high-level global teams and managing collaborations with regulatory authorities and contract research organizations (CROs) demonstrates his capability to bring innovative products to market successfully.

Publication Top Notes

“Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body” – A study exploring CARL in a multicenter setting, highlighting its impact on refractory cardiac arrest patients (2023).
“The Impact of Head Position on Neurological and Histopathological Outcome Following CARL” – Investigates how head positioning affects outcomes in a pig model during CARL (2023).
“Extracorporeal Cardiopulmonary Resuscitation—Evidence and Implications” – Discusses ECPR’s evidence base and its clinical implications (2023).
“Effects of Prolonged Serum Calcium Suppression during ECPR in Pigs” – Examines the effects of serum calcium suppression during ECPR, showing implications for treatment strategies (2023).
“Limiting Calcium Overload after Cardiac Arrest” – Focuses on the role of albumin in reducing calcium overload during CARL (2023).
“Pervasive Platelet Secretion Defects in SARS-CoV-2 Patients” – Analyzes platelet defects in COVID-19 patients and their potential implications for treatment (2023).
“CARL – Controlled Reperfusion of the Whole Body” – A book detailing the CARL procedure, providing a comprehensive resource for clinicians (2022).
“Observational Study on Implications of the COVID-19-Pandemic for Cardiopulmonary Resuscitation” – Examines the pandemic’s impact on resuscitation practices, offering valuable insights (2022).
“Monitoring Mitochondrial Partial Oxygen Pressure During Cardiac Arrest and ECPR” – A pilot study exploring mitochondrial oxygen monitoring during cardiac arrest in a pig model (2021).
“Brain Vulnerability and Viability after Ischaemia” – A review on the neurological outcomes following ischemic events, highlighting vulnerabilities and potential treatment avenues (2021).

Conclusion

Dr. Pooth’s extensive experience, significant contributions to the development and approval of innovative pharmaceutical products, and his leadership in global research and development make him a strong candidate for the “Research for Best Innovation Award.” His work has had a substantial impact on multiple therapeutic areas, including dermatology, immunology, aesthetic medicine, oncology, and neurology, making him well-deserving of recognition in this prestigious category.

Neslihan LOK | Nursing and Health Professions | Best Researcher Award

Posted on 16/07/202416/07/2024 by ScienceFather

Neslihan LOK | Nursing and Health Professions | Best Researcher Award

Assoc Prof Dr Neslihan LOK, Selcuk University, Turkey

Neslihan Lök is an esteemed academic with a doctorate in Psychiatric Nursing from Akdeniz University, completed in 2016. Her master’s thesis, under the guidance of Belgin Akın, focused on environmental risk factors for falls in the elderly. She began her academic journey with a bachelor’s degree from Selçuk University in 2007. As a distinguished scholar, she has held various academic positions at Selçuk University, currently serving as an Associate Professor in the Nursing Faculty. Her research interests include psychosocial interventions, mental health in chronic illness, and geriatric care. Dr. Lök has guided numerous theses and led several significant research projects. 🧠📚👩‍⚕️

Publication profile

google scholar

Education

Dr. Neslihan LOK earned a PhD in Psychiatric Nursing from Akdeniz University on March 31, 2016. Their doctoral thesis, guided by Belgin Akın, focused on environmental risk factors inside homes that contribute to falls among the elderly. They completed a Master’s degree in Public Health Nursing from Selçuk University on September 22, 2010, and a Bachelor’s degree in Nursing from the Karaman Health School of Selçuk University on June 15, 2007. Dr. Neslihan LOK’s academic journey emphasizes their commitment to improving elderly care and public health. 🩺📘🏡

Awards

Dr. Neslihan LOK, recognized for her excellence in presentations, has received multiple awards for her contributions. In 2019, she was honored with the “En İyi Sözel Bildiri Ödülü” by the Her İçin Spor ve Wellness Derneği. She also secured the “Sözel Bildiri İkincilik Ödülü” at Celal Bayar Üniversitesi in 2017 and İstanbul Üniversitesi in 2016. Additionally, she earned the “Sözel Bildiri İkincilik Ödülü” at the V. Uluslararası ve VIII. Ulusal Psikiyatri Hemşireliği Kongresi in 2016. These accolades underscore her impactful work and dedication in her field. 🏆📊🎓

Research focus

Dr. Neslihan Lök’s research focuses primarily on geriatric mental health and caregiving dynamics, emphasizing interventions like physical activity and reminiscence therapy to improve cognitive functions, depression, and quality of life among elderly populations. Her work also explores the impact of domestic environmental factors on falling risks in the elderly. Additionally, Dr. Lök investigates social support’s role in enhancing psychological resilience among caregivers of patients with schizophrenia. Her studies contribute significantly to understanding and enhancing elderly care practices and mental health support systems. 🧠👵🏼🏠

Publication top notes

The effect of physical activity on depressive symptoms and quality of life among elderly nursing home residents: Randomized controlled trial

The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: Randomized controlled trial

Effects of Physical Activity Program on cognitive function and sleep quality in elderly with mild cognitive impairment: A randomized controlled trial

Aile içi şiddetin çocuk üzerindeki etkileri ve psikososyal desteğin önemi

The effects of anger management education on adolescents’ manner of displaying anger and self-esteem: A randomized controlled trial

Relationship between caregiving burden and anger level in primary caregivers of individuals with chronic mental illness

YETİŞKİN BİREYLERDE FİZİKSEL AKTİVİTE ve DEPRESYON ARASINDAKİ İLİŞKİSİNİN BELİRLENMESİ

Domestic environmental risk factors associated with falling in elderly

The relationship between the perceived social support and psychological resilience in caregivers of patients with schizophrenia

Beden eğitimi spor yüksekokulu özel yetenek sinavina girecek adaylarin kaygi durumlarinin bazi değişkenler açisindan incelenmesi

Dan Yan | Medicine and Dentistry | Best Researcher Award

Posted on 10/06/202410/06/2024 by ScienceFather

Dan Yan | Medicine and Dentistry | Best Researcher Award

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. 📚✨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.